Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

Nature Medicine

Volumn 5, Issue 6, 1999, Pages 686-693

  Kirk, Allan D ^a,b,c   Burkly, Linda C ^d   Batty, D Scott ^c   Baumgartner, Roxanne E ^a   Berning, Justin D ^a   Buchanan, Kelvin ^a   Fechner Jr , John H ^b   Germond, Rhonda L ^a   Kampen, Robert L ^a   Patterson, Noelle B ^a   Swanson, S John ^c   Tadaki, Douglas K ^a   TenHoor, Christopher N ^d   White, Leonard ^a   Knechtle, Stuart J ^b   Harlan, David M ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; LIGAND; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RNA; STEROID; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MAJOR HISTOCOMPATIBILITY COMPLEX; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RNA ANALYSIS; T LYMPHOCYTE; THROMBOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; CD40 LIGAND; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKINS; KIDNEY; KIDNEY TRANSPLANTATION; L-SELECTIN; LEUKOCYTE COUNT; LYMPHOCYTES; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MYCOPHENOLIC ACID; RECEPTORS, ANTIGEN, T-CELL; RNA; T-LYMPHOCYTES; TACROLIMUS; TREATMENT OUTCOME;

ANIMALIA; MACACA MULATTA; PRIMATES;

EID: 0032996025     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/9536     Document Type: Article

References (23)

1. Lederman, S. et al. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175, 1091-1101 (1992).
2. Laman, J.D., Claassen E. & Noelle, R.J. Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16, 59-108 (1996).
3. Larsen, C.P. & Pearson, T.C. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr. Opin. Immunol. 9, 641-647 (1997).
4. Harlan, D.M. & Kirk, A.D. Anti-CD154 therapy to prevent graft rejection. Graft 1, 63-70 (1998).
5. Henn, V. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591-594 (1998).
6. Caux, C. et al. Activation of human dendritic cells through CD40 crosslinking. J. Exp. Med. 180, 1263-1272 (1994).
7. Karmann, K. et al. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92, 4342-4346 (1995).
8. Kirk, A.D. et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Nat. Acad. Sc. USA 94, 8789-8794 (1997).
9. Bennett, S.R.M. et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478-480 (1998).
10. Schoenberger, S.P. et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-443 (1998).
11. + T-helper and a T-killer cell. Nature 393, 474-477 (1998).
12. Pirsch, J.D. Long-term management of immunosuppression in the renal transplant patient. Curr. Opin. Organ. Transplant 2, 76-81 (1997).
13. Auphan N. et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270, 286-290 (1995).
14. Plaz, K.P. et al. RS-61443, a new, potent immunosuppressive agent. Transplantation 51, 27-31 (1991).
15. Fruman, D.A., Klee, C.B., Bierer, B.E. & Burakoff, S.J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89, 3686-3690 (1992).
16. Lederman, S.G. et al. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of the T-Cell-B-Cell activating molecule (5c8 antigen) and CD40 in contact dependent help. J. Immunol. 149, 3817-3826 (1992).
17. Yang, Y. & Wilson, J.M. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273, 1862-184 (1996).
18. Konieczny, B.T. et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160, 2059-2064 (1998).
19. + T cells, interferon-gamma, and CTLA4. J. Clin. Invest. 101, 2446-2455 (1998).
20. Knapp, L.A. et al. High-resolution HLA-DRB typing using denaturing gradient gel electrophoresis and direct sequencing. Tissue Antigens 50, 170-177 (1997).
21. Knechtle, S.J. et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 63, 1-6 (1997).
22. Kirk, A.D. et al. Post-transplant diastolic hypertension: associations with intragraft TGF-β, endothelin and renin transcription. Transplantation 64, 1716-1720 (1997).
23. Kirk, A.D., Bollinger, R.R. & Finn, O.J. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Hum Immunol. 43, 113-128 (1995).